EHA-2024-poster-AFM28_final
Loading viewer...
presentation
Format: PDF presentation
This document presents research on AFM28, a bispecific innate cell engager targeting AML, showcasing its anti-tumor activity and potential for long-term remissions.
Loading viewer...
presentation
Format: PDF presentation
This document presents research on AFM28, a bispecific innate cell engager targeting AML, showcasing its anti-tumor activity and potential for long-term remissions.
presentation
presentation
Ernst & Young
presentation
Alcoa Corporation
presentation
Amgen
presentation
Orion Office Reit
